-
Halazone and Sodium Current Inactivation in Frog Nerves
2026-09-25
In voltage-clamped frog nerve fibers, Halazone and hypochlorous acid strongly disrupted sodium current inactivation, while several other oxidants caused only a voltage shift. The comparison argues against a critical role for methionine alone and points—tentatively—to membrane lipid modification, while leaving the molecular target unresolved.
-
PDE Inhibitors Suppress Macrophage Nitric Oxide
2026-09-24
Beshay, Croze, and Prud’homme compared Pentoxifylline and rolipram in activated macrophages, linking reduced nitric oxide production to increased cellular cAMP and lower iNOS mRNA. Their in vitro and in vivo findings provide a mechanistic framework for studying PDE-directed immunomodulation, while showing a substantial potency difference between the two compounds.
-
HRP Rabbit Anti-Goat IgG (H+L) Antibody Guide
2026-09-24
The HRP Rabbit Anti-Goat IgG (H+L) Antibody is an affinity-purified, HRP-conjugated secondary antibody for detecting goat IgG in immunoassays. Its documented applications include western blotting, ELISA, dot blot, and immunohistochemistry, but it does not independently validate biological conclusions from toxicology experiments.
-
H-151 Links STING Inhibition to Ferroptosis Control
2026-09-23
Yin and colleagues report that H-151, beyond inhibiting STING signaling, acts as a radical-trapping antioxidant that suppresses ferroptosis independently of STING. In a murine renal ischemia–reperfusion injury model, this dual activity was associated with less tissue damage and improved renal function, suggesting a mechanism worth testing while leaving questions about dosing, selectivity, and broader applicability open.
-
ML-210 and the New Logic of Ferroptosis Testing
2026-09-23
A mechanistic framework for using ML-210 to interrogate ferroptosis while distinguishing lipid-radical trapping from STING pathway inhibition. The article translates recent H-151 findings into a practical strategy for assay design, validation, and renal ischemia-reperfusion research.
-
12-O-tetradecanoyl phorbol-13-acetate (TPA)
2026-09-22
Learn how 12-O-tetradecanoyl phorbol-13-acetate (TPA), SKU N2060, can standardize ERK/MAPK and protein kinase C signaling experiments while reducing interpretation errors in viability and cytotoxicity workflows. This scenario-based guide covers assay compatibility, solvent handling, timing, data interpretation, and practical vendor selection.
-
Firefly Luciferase mRNA Workflow Guide
2026-09-22
Build more consistent reporter, delivery, and translation studies with a Cap1-capped, 5-moUTP modified mRNA designed for sustained Fluc expression. Practical dosing, handling, normalization, and nanocarrier-comparison guidance helps separate delivery performance from biological response.
-
ER Modulation Meets Breast Cancer Relapse
2026-09-21
A relapse-aware framework for using (Z)-4-Hydroxytamoxifen to connect estrogen receptor pharmacology with proliferation tracing, residual disease biology, and translational breast cancer model selection.
-
ML-210, GPX4, and Ferroptosis Research
2026-09-21
ML-210 is a research compound used to inhibit GPX4 and induce ferroptosis in mechanistic studies. It should not be conflated with H-151, which suppresses ferroptosis through radical-trapping antioxidant activity and STING-independent effects.
-
4-Ethylphenyl Sulfate Research Workflows
2026-09-20
Build reproducible renal biomarker, gut microbiota-brain, neurobehavioral, and biomaterial adsorption assays with 4-ethylphenyl sulfate. This guide translates multi-component PEO adsorption findings into practical preparation, dosing, matrix-spiking, and troubleshooting decisions.
-
Ricin-Triggered Bystander Necroptosis in Lung Cells
2026-09-19
Kempen and colleagues show that ricin-treated monocytic cells can transmit a death signal to neighboring lung epithelial cells, shifting the outcome toward necroptosis rather than the previously described cathepsin-dependent response. The study identifies released ricin, Fas ligand, HMGB1, and HMGB1-RAGE-associated reactive oxygen species as important components of this bystander mechanism, providing a framework for interpreting toxin-driven inflammatory lung injury.
-
ML-210 Ferroptosis Workflow and Mechanism
2026-09-18
Build a controlled ML-210 ferroptosis assay that separates GPX4-pathway stress from STING-linked inflammation. The workflow uses H-151 as a mechanistic contrast, helping researchers avoid misattributing antioxidant rescue to STING inhibition.
-
Separating Arrest from Death in Cancer Drug Assays
2026-09-18
Hannah R. Schwartz’s dissertation shows why relative viability and fractional viability should not be treated as interchangeable measures of anticancer response. Its central contribution is a time-aware framework for distinguishing proliferative arrest from actual cell killing, improving interpretation of drug-response experiments and preclinical assay design.
-
MK-8745: Designing Better Aurora A Assays
2026-09-17
MK-8745 is a potent, selective Aurora A inhibitor for connecting AURKA biology with rigorous cell-cycle and apoptosis assays. This guide translates retinoblastoma evidence into practical model selection, controls, dosing, and interpretation strategies.
-
2,7-Dichlorodihydrofluorescein diacetate: ROS Workflow
2026-09-17
Build a practical DCFH-DA workflow for comparing intracellular oxidative stress across microscopy, flow cytometry, and plate assays. The approach translates the CD44–copper–ROS mechanism reported in inflammatory macrophages into controlled, interpretable experiments while addressing probe specificity and assay artifacts.